Bell's palsy following Growth hormone therapy in a patient with Prader-Willi syndrome: the first report

被引：2

作者：

Dalili, Setila ^{[1
]}

Bidabadi, Elham ^{[2
]}

Behnam, Babak ^{[3
,4
,5
]}

机构：

[1] Rasht Univ Med Sci, Dept Pediat Endocrinol, Pediat Growth Disorders Res Ctr, Sch Med,Shahrivar Hosp 17, Rasht, Iran

[2] Rasht Univ Med Sci, Dept Pediat Neurol, Pediat Growth Disorders Res Ctr, Sch Med,Shahrivar Hosp 17, Rasht, Iran

[3] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA

[4] IUMS, Dept Med Genet & Mol Biol, Fac Med, Tehran, Iran

[5] NHGRI, NIH Undiagnosed Dis Program, Common Fund, Off Clin Director,NIH, Bethesda, MD 20892 USA

来源：

GENETICS AND MOLECULAR RESEARCH | 2018年 / 17卷 / 01期

关键词：

Prader-Willi syndrome; Bell's palsy; Growth Hormone;

D O I：

10.4238/gmr16039877

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Prader-Willi syndrome (PWS) is a complex genetic disorder with different manifestations in infancy and childhood including obesity, type 2 diabetes mellitus, mild to moderate intellectual impairment and learning disabilities. In this syndrome, growth hormone therapy improves outcomes. For the first time, here we report a 11-year-old boy with PWS who presented with three episodes of unilateral facial palsy after starting growth hormone therapy.

引用

页数：4

共 5 条

[1] Long-Term Safety of Recombinant Human Growth Hormone in Children [J].